APA (7th ed.) Citation

Schranz, J., Das, A. F., Alexander, E., Moran, G. J., Sandrock, C., File, T. M., & Gelone, S. P. (2019). 2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results. Open Forum Infectious Diseases, 6, S762. https://doi.org/10.1093/ofid/ofz360.1911

Chicago Style (17th ed.) Citation

Schranz, Jennifer, Anita F. Das, Elizabeth Alexander, Gregory J. Moran, Christian Sandrock, Thomas M. File, and Steven P. Gelone. "2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results." Open Forum Infectious Diseases 6 (2019): S762. https://doi.org/10.1093/ofid/ofz360.1911.

MLA (9th ed.) Citation

Schranz, Jennifer, et al. "2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results." Open Forum Infectious Diseases, vol. 6, 2019, p. S762, https://doi.org/10.1093/ofid/ofz360.1911.